Physician-related factors involved in patient decisions to enroll onto cancer clinical trials
- PMID: 20856718
- PMCID: PMC2790653
- DOI: 10.1200/JOP.0922001
Physician-related factors involved in patient decisions to enroll onto cancer clinical trials
Abstract
The development of new cancer therapies requires additional, and more complex, clinical trials. But only approximately 3% to 5% of adult cancer patients participate in cancer clinical trials. This study seeks to identify and understand the attitudes of the public and cancer survivors toward health-related decisions and cancer clinical trials to identify the key factors that must be addressed to increase that percentage.
References
-
- American Cancer Society: Cancer Facts and Figures 2001. Atlanta, GA, American Cancer Society, 2006
-
- Friedman MA, Cain DF: National Cancer Institute sponsored cooperative clinical trials. Cancer 65:2376-2382, 1990. (10 suppl) - PubMed
-
- Vogelstein B, Kinzler KW: Cancer genes and the pathways they control. Nat Med 10:789-799, 2004 - PubMed
-
- Druker BJ: Circumventing resistance to kinase-inhibitor therapy. N Engl J Med 354:2594-2596, 2006 - PubMed
-
- Comis RL, Miller JD, Aldige CR, et al: Public attitudes toward participation in cancer clinical trials. J Clin Oncol 21:830-835, 2003 - PubMed
LinkOut - more resources
Full Text Sources